GeneDx Holdings (WGS) Inventory (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Inventory data on file, last reported at $12.2 million in Q1 2026.

• Inventory for Q1 2026 came in at $12.2 million, down 3.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.2 million (down 3.32% YoY), and the FY2025 annual result was $14.0 million, up 31.0% from the prior year.
• Inventory declined to $12.2 million in Q1 2026 per WGS's latest filing, from $14.0 million in the prior quarter.
• Over five years, Inventory peaked at $44.2 million in Q3 2022 and troughed at $8.8 million in Q4 2023.
• A 5-year average of $16.6 million and a median of $11.9 million in 2025 frame the typical range for Inventory.
• The sharpest annual moves came in 2022 and 2023: Inventory surged 42.82% in 2022, then tumbled 78.84% in 2023.
• A 5-year view of Inventory shows it stood at $13.7 million in 2022, then sank by 35.77% to $8.8 million in 2023, then grew by 21.34% to $10.6 million in 2024, then jumped by 31.0% to $14.0 million in 2025, then retreated by 12.26% to $12.2 million in 2026.
• Business Quant data shows WGS's Inventory at $12.2 million in Q1 2026, $14.0 million in Q4 2025, and $10.6 million in Q3 2025.